Polaris Wealth Advisory Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Polaris Wealth Advisory Group's BIIB Position: Q4 2018 in Review
Polaris Wealth Advisory Group sold out of Biogen (BIIB) in Q4 2018, closing a stake of 26 shares — an estimated $9K sold.
Polaris Wealth Advisory Group first reported a position in BIIB in Q4 2014 and held it in 6 quarters. The position peaked at $531K in Q2 2015. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.
- Polaris Wealth Advisory Group reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
- Polaris Wealth Advisory Group sold 26 Biogen shares in Q4 2018, an estimated $9K.
- Polaris Wealth Advisory Group first reported a position in Biogen in Q4 2014 and held it in 6 quarters.
- Polaris Wealth Advisory Group's Biogen position peaked at $531K in Q2 2015.
- 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.
Based on Polaris Wealth Advisory Group's 13F filing for Q4 2018, filed 17 Jan 2019.